Author | Carlos R. Bachier, MD | OncLive

Author | Carlos R. Bachier, MD

Articles

Dr. Bachier on the Potential Benefits of Liso-Cel in DLBCL

September 17, 2020

Carlos R. Bachier, MD, discusses the investigational CAR T-cell therapy lisocabtagene maraleucel in diffuse large B-cell lymphoma.

Dr. Bachier on the Toxicity Profile of Liso-Cel

February 21, 2020

Carlos R. Bachier, MD, discusses the toxicity profile of lisocabtagene maraleucel that has been observed in 3 ongoing clinical trials in relapsed/refractory large B-cell non-Hodgkin lymphoma.

Dr. Bachier Discusses Toxicities With Stem Cell Transplant

March 30, 2018

Carlos R. Bachier, MD, director, blood and marrow transplant research, Sarah Cannon Research Institute, discusses toxicities associated with stem cell transplant.

Dr. Bachier Discusses CAR T-Cell Therapy and Stem Cell Transplant

March 13, 2018

Carlos R. Bachier, MD, program director of Sarah Cannon Center for Blood Cancer, Sarah Cannon Research Institute, discusses the relationship between chimeric antigen receptor (CAR) T-cell therapy and stem cell transplant.

x